YAHOO NEWS (ALEX WONG)
August 12, 2020, 4:42 AM·2 mins read
President Donald Trump on Tuesday announced a $1.5 billion contract with US biotech company Moderna for 100 million doses of an eventual coronavirus vaccine, the sixth such deal reached since May. This is 6th vaccine contract announced in USA.
“I’m pleased to announce that we have reached an agreement with Moderna to manufacture and deliver 100 million doses of their coronavirus vaccine candidate,” Trump said at a White House news conference.
“The federal government will own these vaccine doses, we’re buying them.”
“We’re on track to rapidly produce 100 million doses as soon as the vaccine is approved, and up to 500 million shortly thereafter, so we’ll have 600 million doses,” he added.
Moderna, in partnership with the US National Institutes of Health (NIH), is conducting Phase 3 clinical trials of a vaccine candidate and manufacturing of vaccine doses will take place while the trials are underway.
The vaccine, called mRNA-1273, is being co-developed by Moderna and the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), which is led by Dr Anthony Fauci.
Fauci has said researchers are unlikely to know the efficacy of the vaccine before the end of the year at the earliest. But Trump has said he hopes to have a vaccine before the November 3 presidential election.
The latest contract brings the US government’s total commitments to Moderna to $2.48 billion.
The company, founded less than 10 years ago, has not previously developed a vaccine of any kind but preliminary results of the company’s experimental COVID-19 vaccine have reportedly produced promising results.
The Trump administration has allocated a total of at least $10.9 billion for the development and manufacturing of a coronavirus vaccine.
It has already ordered 100 million vaccine doses from Johnson & Johnson, Novavax, Pfizer and Sanofi and 300 million from AstraZeneca.

Thewriterfriends.com is an experiment to bring the creative people together on one platform. It is a free platform for creativity. While there are hundreds, perhaps thousands of platforms that provide space for expression around the world, the feeling of being a part of fraternity is often lacking. If you have a creative urge, then this is the right place for you. You are welcome here to be one of us.
JUST ANNOUNCED: US_FDA has issued an emergency use authorization for convalescent plasma as a treatment for Coronavirus.
The White House (@WhiteHouse) August 23, 2020
We determined that it is reasonable to believe that #COVID19 convalescent plasma may be effective in lessening the severity or shortening the length of COVID-19 illness in some patients.
August 23, 2020
More than 64,000 patients in the US have been given convalescent plasma, a century-old approach to fend off flu and measles before vaccines. It’s a go-to tactic when new diseases come along, and history suggests it works against some, but not all, infections.
Good thoughts… but we have to wait. No one knows at this time which Pharma companies will be successful… many in the race to win now… may be risking their investments. The vaccine that US is banking on is yet to be tested on senior citizens in large double blind clinical trials. Hope to see an announcement by Nov 3, election day, on success or failure in this phase 3 trials.
I think, it will be a good bet to pick up stocks of some of these Pharma Companies. With almost every day, someone claiming to have reached another milestone, the race is really hotting up. I won’t be surprised to see the vegetable vendors on Indian streets selling the phials by weight :))